Literature DB >> 22291032

Factors associated with emotional and behavioral outcomes in adolescents with multiple sclerosis.

C Till1, E Udler, R Ghassemi, S Narayanan, D L Arnold, B L Banwell.   

Abstract

BACKGROUND: Multiple sclerosis (MS) onset during adolescence has the potential to disrupt a key period of psychosocial maturation.
OBJECTIVE: We aimed to examine the prevalence and risk factors associated with emotional and behavioral outcomes in adolescents with MS.
METHODS: The Behavioral Assessment System for Children-2nd Edition (BASC-2) was completed by 31 adolescents with MS (mean age = 16.1 years), 31 age-matched controls, and parents of all participants. BASC-2 outcomes were compared between groups. Base rates were examined for scores falling at least one or two standard deviations below norm. Associations between BASC-2 outcomes and features of disease severity and IQ were examined.
RESULTS: Youth with MS were reported by their parents to have more symptoms of depression and somatization and lower adaptive skills compared with reports by parents of controls. On the self-report, patients endorsed more problems of inattention/hyperactivity and lower self-reliance relative to controls. Behavioral concerns and reduced adaptive functioning in the MS group were associated with fatigue, poor relations with parents, and perceived social stress. Psychosocial outcomes did not associate with number of relapses, Expanded Disability Status Scale score, disease duration, brain lesion volume or IQ.
CONCLUSION: Youth with MS are at risk of difficulties in behavioral and emotional health. Relations with parents emerged as a key factor influencing the emotional well-being of youth with MS, suggesting an important role for family-centered care in this population.

Entities:  

Mesh:

Year:  2012        PMID: 22291032     DOI: 10.1177/1352458511433918

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study.

Authors:  A Ghezzi; A Bianchi; D Baroncini; A Bertolotto; S Malucchi; V Bresciamorra; R Lanzillo; N Milani; V Martinelli; F Patti; C Chisari; M Rottoli; M Simone; D Paolicelli; A Visconti
Journal:  Neurol Sci       Date:  2017-08-22       Impact factor: 3.307

2.  Behavioral Symptoms in Pediatric Multiple Sclerosis: Relation to Fatigue and Cognitive Impairment.

Authors:  Leigh Charvet; Bianca Cersosimo; Colleen Schwarz; Anita Belman; Lauren B Krupp
Journal:  J Child Neurol       Date:  2016-03-09       Impact factor: 1.987

Review 3.  Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis.

Authors:  Marisa McGinley; Ian T Rossman
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 4.  Pediatric Multiple Sclerosis: an Update.

Authors:  Scott Otallah; Brenda Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-18       Impact factor: 5.081

Review 5.  The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.

Authors:  Ruth Ann Marrie; Stephen Reingold; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sorensen; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-12       Impact factor: 6.312

6.  Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).

Authors:  Mahsa Ghajarzadeh; Mahsa Owji; Mohammad Ali Sauraian; Abdorreza Naser Moghadasi; Amirreza Azimi
Journal:  Iran J Public Health       Date:  2014-11       Impact factor: 1.429

Review 7.  Cognitive dysfunction in pediatric multiple sclerosis.

Authors:  Agnese Suppiej; Elisa Cainelli
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-23       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.